Segments - Artificial Intelligence (AI) in Telemedicine Market by Type (Services and Software), Application (Virtual Nursing Assistant, Preliminary Diagnosis, Administrative Workflow Assistance, Clinical Trials, and Others), End-user (Homecare, Healthcare Facilities, and Others), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
The global artificial intelligence (AI) in telemedicine market size was USD XX Billion in 2022 and is likely to reach USD XX Billion by 2031, expanding at a CAGR of XX% during 2023–2031. The market is driven by the upsurge in teleconsultation services and the advancement in information technology.
Improved diagnostic accuracy and medical imaging analysis provided by the implementation of artificial intelligence in the field of telemedicine are expected to boost the market during the assessment period. AI assists healthcare professionals in the interpretation of MRIs and X-rays, leading to a faster and more precise diagnosis.
As per the report published by the National Institute of Health in January 2023, the implementation of AI in all the fields of medicine is increasing. It is anticipated to help with personalized prognosis and comprehensive diagnosis for the patients. Its application in radiology is rapidly gaining importance.
Global growth of the geriatric population and the increasing prevalence of chronic diseases require extensive management of patient records. The use of AI facilitates workflow automation, completely streamlining administrative tasks such as medical record management and appointment scheduling. Furthermore, features of AI such as content analytics, deep learning technologies, and Natural Language Processing (NLP) are assisting healthcare providers in the early diagnosis of underlying health conditions of the patient.
The research report finds that the COVID-19 pandemic boosted the market, due to the increased demand for telemedicine facilities owing to the pandemic restrictions. Various governments all around the world, imposed lockdowns to prevent the spread of infection. Moreover, people avoided visiting hospitals for minor health issues to minimize the risk of getting infected. As a result, a large number of people opted for telemedicine services to get initial health diagnoses. The use of AI in telemedicine services aided in accurate diagnosis with the help of virtual nursing assistants.
Augmenting the necessity for remote patient monitoring is expected to drive the market during the projection period. The upsurge in the geriatric population and growth in chronic diseases has led to a rapid increase in the requirement for telemedicine services. Integration of AI with telehealth and telemedicine services facilitates preliminary diagnosis through online consultation and virtual nursing platforms for patients. The implementation of artificial intelligence has considerably enhanced the functionality of telemedicine services and is likely to provide major propulsion for artificial intelligence (AI) in the telemedicine market.
Growing operational complexities and the risk of data breaches are likely to hamper the market during the forecast period. Though AI brought significant advancements in the field of telemedicine problems such as inconsistencies in diagnosis, prescribed medicines, and the risk to data privacy have significantly increased. This endangers patient safety through an unethical gathering of their data. Thus, these factors are potentially restraining the market during the forecast period.
Increasing investment of healthcare companies in artificial intelligence is anticipated to provide substantial growth opportunities for the market. Various MedTech and pharmaceutical companies are making substantial investments in the application of artificial intelligence in digital healthcare and medicine. AI helps in performing operational activities efficiently and cost-effectively. In addition, it enables healthcare professionals to detect diseases early and provide effective diagnoses to patients at remote locations. For instance,
In March 2022, Microsoft Corporation, the global leader among tech giants, announced the complete acquisition of Nuance, a company known for its artificial intelligence and speech recognition software. The deal was finalized for USD 19.7 billion and is expected to enhance the functioning of Microsoft Cloud for Healthcare in patient engagement and operational data insights.
The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Artificial Intelligence (AI) in Telemedicine Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2022 |
Historic Data |
2016–2021 |
Forecast Period |
2023–2031 |
Segmentation |
Type (Services and Software), Application (Virtual Nursing Assistant, Preliminary Diagnosis, Administrative Workflow Assistance, Clinical Trials, and Others), and End-user (Homecare, Healthcare Facilities, and Others) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
Key Players Covered in the Report |
Ada Health GmbH; CAE Healthcare Inc.; Cisco Systems, Inc.; HealthTap, Inc.; Hologic, Inc.; IBM; Koninklijke Philips N.V.; LEMONAID HEALTH INC.; Lifesize; and Siemens Healthcare GmbH. |
Based on type, the artificial intelligence in telemedicine market is divided into services and software. The software segment is projected to hold the major share of the market during the projection period, due to the increased adoption of AI-based telemedicine software applications by healthcare professionals and patients. Various top healthcare companies are collaborating with software developers for the planning and development of such applications. With the rising popularity of telemedicine services, this segment is anticipated to have significant growth during the forecast period.
As per the report published by the National Institute of Health in July 2021, telemedicine is found to aid medical professionals in diagnosing and treating patients even in remote areas. The use of health apps allows for scheduled follow-up visits, which makes the treatment more effective by reducing the probability of missed appointments and optimizing patient outcomes.
The service segment is projected to register a considerable CAGR during the forecast period, owing to its high usage in recent years. These services assist with monitoring the patient’s vitals and connect them to a physician if required. They enable the patient to connect immediately to their healthcare team through the medium of their choice. With the growth of the geriatric population and the rising prevalence of chronic health issues, this segment is projected to have substantial propulsion in the coming years.
On the basis of application, the global market is segregated into virtual nursing assistants, preliminary diagnosis, administrative workflow assistance, clinical trials, and others. The virtual nursing assistant segment is projected to register a high CAGR during the forecast period, due to its ability to simplify the use of telemedicine applications for users.
A large number of people using telemedicine services are elderly people or individuals living in remote locations. Most of them find it difficult to operate modern telemedicine applications, due to the lack of healthcare facilities available nearby. The use of an AI-based virtual nursing assistant allows them to access their medical records, obtain personalized treatment plans, and avail of teleconsultation services from an expert physician at their home. With increasing dependence on telemedicine services, this segment is likely to have considerable growth during the projection period.
Based on end-user, the global market is segmented into homecare, healthcare facilities, and others. The homecare segment is expected to drive the market during the assessment period, as it provides prompt healthcare support to people who are unable to visit a nearby healthcare center and are suffering from chronic health conditions such as diabetes and asthma.
The use of telemedicine in home setups makes healthcare easier for people living in distant remote locations. Furthermore, the use of telehealth services at homecare is highly convenient and cost-effective as it reduces the waiting time and transportation expenses, and is expected to provide major propulsion for this segment.
In terms of region, the global artificial intelligence in telemedicine market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to dominate the market during the projection period, due to the high adoption of AI in medical technology. Several key players are making a lot of efforts to get authorization from the regulatory bodies for the implementation of AI and machine learning in medical technology. Furthermore, the increasing trend of telemedicine is anticipated to deliver a substantial push to the growth of the market in this region.
Asia Pacific is expected to witness major advancements in the market during the forecast period, owing to their rising healthcare standards, expanding medical infrastructure, and development in information technology. Other factors contributing to the development of the market include modern lifestyle, upsurge in per capita income, and large population in countries such as India and China. In addition, the increase in geriatric population in this region is projected to offer considerable opportunities for the growth of the market.
The artificial intelligence (AI) in telemedicine market has been segmented on the basis of
Key players competing in the global artificial intelligence in telemedicine market are Ada Health GmbH; CAE Healthcare Inc.; Cisco Systems, Inc.; HealthTap, Inc.; Hologic, Inc.; IBM; Koninklijke Philips N.V.; LEMONAID HEALTH INC.; Lifesize; and Siemens Healthcare GmbH.
These companies adopt development strategies such as acquisitions, product launches, partnerships, mergers, collaboration, and production expansion to expand their consumer base worldwide. These key players make heavy investments in research & innovation to stay ahead of the curve. For instance,
In March 2022, Microsoft Corporation made important technological advancements in the healthcare cloud and Azure Health Data services. These advancements include updated health bot templates, improved integration of clinical workflow, and new patient insight features.
In November 2021, Altivity, a new innovative brand from CANON MEDICAL SYSTEMS EUROPE B.V., uses a combination of machine learning and need learning technologies powered by AI. This new technology is used in medical imaging systems like MRI, which reduces scanning time and provides images with improved quality.